Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients

Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients

Cisplatin-containing chemotherapy represents the first-line treatment for patients with locally advanced or metastatic muscle-invasive bladder cancer. Recently, novel therapies have become available for cisplatin-ineligible or -resistant patients. Therefore, prediction of cisplatin response is requi...

Full description

Bibliographic Details
Main Authors: Csilla Olah, Stephan Tschirdewahn, Michèle J. Hoffmann, Ulrich Krafft, Boris Hadaschik, Peter Nyirady, Attila Szendröi, Orsolya Módos, Anita Csizmarik, Ilona Kovalszky, Henning Reis, Tibor Szarvas
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Diagnostics
Subjects:
muscle-invasive bladder cancer
SDC1
chemotherapy
cisplatin
metastasis
Matrix Metalloproteinase—7 (MMP-7)
Online Access:https://www.mdpi.com/2075-4418/10/11/864

Internet

https://www.mdpi.com/2075-4418/10/11/864

Similar Items